1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

0HD2.L
Alnylam Pharmaceuticals, Inc.GB flagLondon Stock Exchange
319.29
USD
+5.45
- -
42.63BMarket Cap

Total Valuation

Alnylam Pharmaceuticals, Inc. carries a market capitalization of 42.63B, placing it among publicly traded companies globally.

Market Cap42.63B
Enterprise ValueN/A

Stock Price Statistics

Alnylam Pharmaceuticals, Inc.'s stock has gained approximately 0.56377953% over the past 52 weeks. The 50-day moving average sits at 170.73, while the 200-day moving average is 180.79.

Beta (5Y)N/A
52-Week Price Change0.56377953%
50-Day Moving Average170.73
200-Day Moving Average180.79
Average Volume (20 Days)N/A